US20200022696A1 - Post-Implantation Tension Adjustment in Cardiac Implants - Google Patents
Post-Implantation Tension Adjustment in Cardiac Implants Download PDFInfo
- Publication number
- US20200022696A1 US20200022696A1 US16/564,809 US201916564809A US2020022696A1 US 20200022696 A1 US20200022696 A1 US 20200022696A1 US 201916564809 A US201916564809 A US 201916564809A US 2020022696 A1 US2020022696 A1 US 2020022696A1
- Authority
- US
- United States
- Prior art keywords
- coupling
- tissue anchor
- tissue
- coupling element
- site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0412—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0461—Means for attaching and blocking the suture in the suture anchor with features cooperating with special features on the suture, e.g. protrusions on the suture
- A61B2017/0462—One way system, i.e. also tensioning the suture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
Definitions
- the present invention relates generally to minimally-invasive valve repair, and more specifically to minimally-invasive methods for repairing the tricuspid valve.
- Functional tricuspid regurgitation is governed by several pathophysiologic abnormalities such as tricuspid valve annular dilatation, annular shape, pulmonary hypertension, left or right ventricle dysfunction, right ventricle geometry, and leaflet tethering. Treatment options for FTR are primarily surgical.
- U.S. Pat. No. 8,475,525 to Maisano et al. describes a method that includes implanting at least a first tissue-engaging element in a first portion of tissue in a vicinity of a heart valve of a patient, implanting at least a second tissue-engaging element in a portion of a blood vessel that is in contact with an atrium of a heart of the patient, and drawing at least a first leaflet of the valve toward at least a second leaflet of the valve by adjusting a distance between the portion of the blood vessel and the first portion of tissue in the vicinity of the heart valve of the patient.
- a proximal end portion of a longitudinal member is shaped so as to define one or more engaging elements (e.g., hooks or barbs), which are coupleable with the struts of a stent member in order to maintain the tension applied to a longitudinal member for remodeling the tricuspid valve.
- engaging elements e.g., hooks or barbs
- Some applications of the present invention provide a method of treating a heart of a patient, such as to reduce tricuspid valve regurgitation.
- the method includes implanting a first tissue anchor in cardiac tissue of the patient, and a second tissue anchor in the patient.
- the first tissue anchor is attached to one or more tethers that are fixed to a coupling element.
- the coupling element is coupled to a first coupling site of the second tissue anchor, thereby coupling the first tissue anchor to the second tissue anchor via the one or more tethers.
- tension is increased between the first and the second tissue anchors by decoupling the coupling element from the first coupling site and coupling the coupling element to a second coupling site of the second tissue anchor.
- a method of treating a heart of a patient including:
- first tissue anchor in cardiac tissue of the patient, the first tissue anchor attached to one or more tethers that are fixed to a coupling element;
- the one or more tethers are slack before increasing the tension.
- the coupling element includes a hook.
- the coupling element is shaped so as to define an opening, and coupling the coupling element to the first coupling site includes coupling the opening to the first coupling site.
- the coupling element includes a loop, which is shaped to define the opening.
- the second tissue anchor includes a stent that includes a plurality of struts, which define the first and the second coupling sites.
- the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
- one or more of the struts extend radially inward at the first and the second couplings sites to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
- the second tissue anchor includes hooks at the first and the second coupling sites, respectively.
- At least one of the struts is oriented axially along the stent, and the axially-oriented strut defines the first and the second coupling sites.
- the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
- the axially-oriented strut is wider than others of the struts so as to serve as a backbone for the stent.
- increasing the tension includes increasing the tension after allowing at least one week for tissue growth on the first tissue anchor.
- increasing the tension includes increasing the tension within two months after implanting the first tissue anchor.
- the coupling element is a first coupling element
- the one or more tethers are additionally fixed to a second coupling element
- coupling the coupling element to the first coupling site includes coupling one or more of the first and the second coupling elements to a plurality of first coupling sites.
- coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site after implanting the first and the second tissue anchors.
- coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site before implanting the first and the second tissue anchors.
- coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site after implanting the first tissue anchor and before implanting the second tissue anchor.
- the coupling element is coated with a tissue-growth-inhibiting coating.
- the first and the second coupling sites are coated with a tissue-growth-inhibiting coating.
- the first tissue anchor includes a helical tissue-anchoring element.
- implanting the first tissue anchor includes implanting the first tissue anchor in the vicinity of the tricuspid valve of the patient.
- implanting the second tissue anchor includes implanting the second tissue anchor in a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.
- SVC superior vena cava
- IVC inferior vena cava
- coronary sinus a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.
- a system for treating a heart of a patient including:
- a first tissue anchor which is configured to be implanted in cardiac tissue of the patient
- one or more tethers which are attached to the first tissue anchor and are fixed to the coupling element;
- a second tissue anchor which is configured to be implanted in the patient, and which includes a stent that includes a plurality of struts, which define first and second coupling sites to which the coupling element is configured to be coupled so as to couple the first tissue anchor to the second tissue anchor via the one or more tethers, wherein the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent,
- the coupling element is coupleable to the first coupling site, and thereafter decouplable from the first coupling site and couplable to the second coupling site so as to increase tension between the first and the second tissue anchors.
- the coupling element is shaped so as to define an opening, which is configured to be coupled to the first and the second coupling sites.
- the coupling element includes a loop, which is shaped to define the opening.
- the second tissue anchor includes hooks at the first and the second coupling sites, respectively.
- At least one of the struts is oriented axially along the stent, and the axially-oriented strut defines the first and the second coupling sites.
- the axially-oriented strut is wider than others of the struts so as to serve as a backbone for the stent.
- one or more of the struts extend radially inward at the first and the second couplings sites to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
- the coupling element is a first coupling element
- the system includes a second coupling element, which is fixed to the one or more tethers.
- the coupling element is coated with a tissue-growth-inhibiting coating.
- the first and the second coupling sites are coated with a tissue-growth-inhibiting coating.
- the first tissue anchor includes a helical tissue-anchoring element.
- FIGS. 1A-C are schematic illustrations of a method of treating a heart of a patient, in accordance with an application of the present invention.
- FIGS. 2A-C are schematic illustrations of a method of treating a heart of a patient, in accordance with an application of the present invention.
- FIGS. 1A-C and 2 A-C are schematic illustrations of methods of treating a heart 10 of a patient, in accordance with respective applications of the present invention.
- the methods are performed to treat a tricuspid valve 20 , such as by reducing tricuspid valve regurgitation.
- a first tissue anchor 30 is implanted in cardiac tissue of the patient, such as in the vicinity of tricuspid valve 20 .
- First tissue anchor 30 is attached to one or more tethers 32 that are fixed to a coupling element 34 , such as a hook, as shown in FIG. 1A , or an opening, as shown in FIG. 1B .
- coupling element 34 comprises a loop, which is shaped so as to define the opening (configuration not shown).
- a coupling support structure 36 is provided, which comprises coupling element 34 and attaches coupling element 34 to the one or more tethers 32 .
- a second tissue anchor 40 is implanted in the patient, either before or after implanting first tissue anchor 30 , such as in a superior vena cava (SVC) 42 , an inferior vena cava (IVC) 44 (as shown), and a coronary sinus 46 .
- first and second tissue anchors 30 and 40 are implanted in a transcatheter procedure (typically endovascularly, such as percutaneously), via a catheter, such as described in the applications incorporated hereinbelow by reference.
- the one or more tethers 32 comprise two tethers 32 that are coupled together in situ during the first stage of the implantation procedure, such as using techniques described in one or more of the applications incorporated by reference hereinbelow.
- coupling element 34 is coupled to a first coupling site 50 of second tissue anchor 40 , thereby coupling first tissue anchor 30 to second tissue anchor 40 via the one or more tethers 32 .
- Coupling element 34 may be coupled to first coupling site 50 either after or before implanting first and second tissue anchors 30 and 40 , or after implanting first tissue anchor 30 and before implanting second tissue anchor 40 .
- the one or more tethers 32 are slack, i.e., do not apply tension between first and second tissue anchors 30 and 40 .
- first tissue anchor 30 thereafter, during a second stage of the implantation procedure, typically after allowing at least 24 hours (e.g., at least one week, such as at least one month) for tissue growth (e.g., fibrous and/or endothelial tissue growth) on first tissue anchor 30 to strengthen anchoring of first tissue anchor 30 in the cardiac tissue, tension is increased between first and second tissue anchors 30 and 40 by decoupling coupling element 34 from first coupling site 50 and coupling coupling element 34 to a second coupling site 52 of second tissue anchor 40 (different from first coupling site 50 ). For some applications, the tension is increased within two months after implanting first tissue anchor 30 .
- tissue growth e.g., fibrous and/or endothelial tissue growth
- second coupling site 52 is farther from first tissue anchor 30 than first coupling site 50 is from first tissue anchor 30 .
- application of the tension remodels tricuspid valve 20 , by drawing two or three of the leaflets together to enhance coaptation.
- the procedure may optionally include subsequent stages (e.g., a third stage) after the second stage (e.g., at least 24 hours after the second stage), in which tension is further increased by decoupling coupling element from its current coupling site (e.g., coupling site 50 ) and coupling coupling element 34 to yet another coupling site (e.g., a third coupling site).
- a tool 54 is introduced through the vasculature via a catheter 56 , and used to recapture coupling element 34 .
- tool 54 may comprise a lasso 58 , which is used to engage a hook 60 of coupling element 34 .
- the hook may extend radially inward into a lumen of second tissue anchor 40 in order to facilitate engagement by tool 54 (e.g., lasso 58 ) when tool 54 has been introduced into the lumen of second tissue anchor 40 .
- second tissue anchor 40 comprises a stent 70 that comprises a plurality of struts 72 , which define first and second coupling sites 50 and 52 .
- first and second coupling sites 50 and 52 extend radially inward (i.e., toward a central longitudinal axis of stent 70 ) to facilitate the coupling of coupling element 34 to first and second coupling sites 50 and 52 from within stent 70 .
- FIGS. 1A-C and 2 A-C first and second coupling sites 50 and 52 extend radially inward (i.e., toward a central longitudinal axis of stent 70 ) to facilitate the coupling of coupling element 34 to first and second coupling sites 50 and 52 from within stent 70 .
- one or more of struts 72 extend radially inward at first and second couplings sites 50 and 52 to facilitate the coupling of coupling element 34 to first and second coupling sites 50 and 52 from within stent 70 .
- second tissue anchor 40 comprises hooks (which are optionally shaped as tabs, as shown in FIGS. 2A-C ) at first and second coupling sites 50 and 52 , respectively; the hooks, and thus first and second coupling sites 50 and 52 , extend radially inward (optionally, one or more of struts 72 (e.g., axially-oriented strut 74 , described immediately below) also extend radially inward).
- At least one 74 of struts 72 is oriented axially along the stent, and axially-oriented strut 74 defines first and second coupling sites 50 and 52 .
- axially-oriented strut 74 is wider than others of struts 72 so as to serve as a backbone for the stent. (Although not illustrated, this backbone may also be provided for the configuration shown in FIGS. 1A-C .)
- first tissue anchor 30 comprises a helical tissue-anchoring element.
- fibrous glue is applied to the tissue-coupling element to help secure the anchor in place and minimize detachment.
- tissue-growth-enhancing coating is also applied to the tissue-coupling element.
- coupling element 34 is a first coupling element 34
- the one or more tethers 32 are additionally fixed to a second coupling element 78 , such as a hook, as shown in FIGS. 1A-C , or an opening, as shown in FIGS. 2A-C (or to more than two coupling elements, such as shown in FIGS. 2A-C );
- coupling support structure 36 may comprise second coupling element 78 in addition to first coupling element 34 .
- coupling coupling element 34 to first coupling site 50 comprises coupling one or more of first and second coupling elements 34 and 78 to a plurality of first coupling sites 50 .
- Providing a plurality of coupling elements provides redundancy; in case one of the coupling elements does not catch on second tissue anchor 40 , another of the coupling elements may catch (or both may catch, as shown in the figures).
- first and second coupling elements 34 and 78 are arranged along coupling support structure 36 , optionally at a distance apart that is the same as a distance between first and second coupling sites 50 and 52 , such that when first coupling element 34 is repositioned from first coupling site 50 to second coupling site, as described hereinabove with reference to FIGS. 1B-C and 2 B-C, second coupling element 78 is repositioned from a third coupling site 80 to first coupling site 50 , i.e., takes the coupling site vacated by first coupling element 34 .
- coupling element 34 , first coupling site 50 , and/or second coupling site 52 are coated with a tissue-growth-inhibiting coating (e.g., silicone). Such coating may facilitate the decoupling of coupling element 34 from first coupling site 50 and/or the coupling of coupling element 34 to second coupling site 52 , as described hereinabove with reference to FIGS. 1B-C and 2 B-C.
- a tissue-growth-inhibiting coating e.g., silicone
Abstract
A method of treating a heart of a patient is provided, including implanting a first tissue anchor in cardiac tissue of the patient, the first tissue anchor attached to one or more tethers that are fixed to a coupling element. A second tissue anchor is implanted in the patient. The coupling element is coupled to a first coupling site of the second tissue anchor, thereby coupling the first tissue anchor to the second tissue anchor via the one or more tethers. Thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, tension is increased between the first and the second tissue anchors by decoupling the coupling element from the first coupling site and coupling the coupling element to a second coupling site of the second tissue anchor. Other embodiments are also described.
Description
- The present application is a continuation of U.S. Non-Provisional Application 15/903,619, filed on Feb. 23, 2018, which claims the benefit of U.S. Provisional Application 62/465,400, filed Mar. 1, 2017, which is assigned to the assignee of the present application and each is incorporated herein by reference in its entirety. The present application is related to an international application to Denti et al. filed on even date herewith, entitled, “Post-implantation tension adjustment in cardiac implants.”
- The present invention relates generally to minimally-invasive valve repair, and more specifically to minimally-invasive methods for repairing the tricuspid valve.
- Functional tricuspid regurgitation (FTR) is governed by several pathophysiologic abnormalities such as tricuspid valve annular dilatation, annular shape, pulmonary hypertension, left or right ventricle dysfunction, right ventricle geometry, and leaflet tethering. Treatment options for FTR are primarily surgical.
- U.S. Pat. No. 8,475,525 to Maisano et al. describes a method that includes implanting at least a first tissue-engaging element in a first portion of tissue in a vicinity of a heart valve of a patient, implanting at least a second tissue-engaging element in a portion of a blood vessel that is in contact with an atrium of a heart of the patient, and drawing at least a first leaflet of the valve toward at least a second leaflet of the valve by adjusting a distance between the portion of the blood vessel and the first portion of tissue in the vicinity of the heart valve of the patient. In one configuration, a proximal end portion of a longitudinal member is shaped so as to define one or more engaging elements (e.g., hooks or barbs), which are coupleable with the struts of a stent member in order to maintain the tension applied to a longitudinal member for remodeling the tricuspid valve.
- Some applications of the present invention provide a method of treating a heart of a patient, such as to reduce tricuspid valve regurgitation. The method includes implanting a first tissue anchor in cardiac tissue of the patient, and a second tissue anchor in the patient. The first tissue anchor is attached to one or more tethers that are fixed to a coupling element. The coupling element is coupled to a first coupling site of the second tissue anchor, thereby coupling the first tissue anchor to the second tissue anchor via the one or more tethers. Thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, tension is increased between the first and the second tissue anchors by decoupling the coupling element from the first coupling site and coupling the coupling element to a second coupling site of the second tissue anchor.
- There is therefore provided, in accordance with an application of the present invention, a method of treating a heart of a patient, including:
- implanting a first tissue anchor in cardiac tissue of the patient, the first tissue anchor attached to one or more tethers that are fixed to a coupling element;
- implanting a second tissue anchor in the patient;
- coupling the coupling element to a first coupling site of the second tissue anchor, thereby coupling the first tissue anchor to the second tissue anchor via the one or more tethers; and
- thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, increasing tension between the first and the second tissue anchors by decoupling the coupling element from the first coupling site and coupling the coupling element to a second coupling site of the second tissue anchor.
- For some applications, the one or more tethers are slack before increasing the tension.
- For some applications, the coupling element includes a hook.
- For some applications, the coupling element is shaped so as to define an opening, and coupling the coupling element to the first coupling site includes coupling the opening to the first coupling site. For some applications, the coupling element includes a loop, which is shaped to define the opening.
- For some applications, the second tissue anchor includes a stent that includes a plurality of struts, which define the first and the second coupling sites. For some applications, the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent. For some applications, one or more of the struts extend radially inward at the first and the second couplings sites to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent. For some applications, the second tissue anchor includes hooks at the first and the second coupling sites, respectively.
- For some applications, at least one of the struts is oriented axially along the stent, and the axially-oriented strut defines the first and the second coupling sites. For some applications, the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent. For some applications, the axially-oriented strut is wider than others of the struts so as to serve as a backbone for the stent.
- For some applications, increasing the tension includes increasing the tension after allowing at least one week for tissue growth on the first tissue anchor.
- For some applications, increasing the tension includes increasing the tension within two months after implanting the first tissue anchor.
- For some applications, the coupling element is a first coupling element, and the one or more tethers are additionally fixed to a second coupling element, and coupling the coupling element to the first coupling site includes coupling one or more of the first and the second coupling elements to a plurality of first coupling sites.
- For some applications, coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site after implanting the first and the second tissue anchors.
- For some applications, coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site before implanting the first and the second tissue anchors.
- For some applications, coupling the coupling element to the first coupling site includes coupling the coupling element to the first coupling site after implanting the first tissue anchor and before implanting the second tissue anchor.
- For some applications, the coupling element is coated with a tissue-growth-inhibiting coating.
- For some applications, the first and the second coupling sites are coated with a tissue-growth-inhibiting coating.
- For some applications, the first tissue anchor includes a helical tissue-anchoring element.
- For some applications, implanting the first tissue anchor includes implanting the first tissue anchor in the vicinity of the tricuspid valve of the patient.
- For some applications, implanting the second tissue anchor includes implanting the second tissue anchor in a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.
- There is further provided, in accordance with an application of the present invention, a system for treating a heart of a patient, including:
- a first tissue anchor, which is configured to be implanted in cardiac tissue of the patient;
- a coupling element;
- one or more tethers, which are attached to the first tissue anchor and are fixed to the coupling element; and
- a second tissue anchor, which is configured to be implanted in the patient, and which includes a stent that includes a plurality of struts, which define first and second coupling sites to which the coupling element is configured to be coupled so as to couple the first tissue anchor to the second tissue anchor via the one or more tethers, wherein the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent,
- wherein the coupling element is coupleable to the first coupling site, and thereafter decouplable from the first coupling site and couplable to the second coupling site so as to increase tension between the first and the second tissue anchors.
- For some applications, the coupling element is shaped so as to define an opening, which is configured to be coupled to the first and the second coupling sites. For some applications, the coupling element includes a loop, which is shaped to define the opening.
- For some applications, the second tissue anchor includes hooks at the first and the second coupling sites, respectively.
- For some applications, at least one of the struts is oriented axially along the stent, and the axially-oriented strut defines the first and the second coupling sites. For some applications, the axially-oriented strut is wider than others of the struts so as to serve as a backbone for the stent.
- For some applications, one or more of the struts extend radially inward at the first and the second couplings sites to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
- For some applications, the coupling element is a first coupling element, and the system includes a second coupling element, which is fixed to the one or more tethers.
- For some applications, the coupling element is coated with a tissue-growth-inhibiting coating.
- For some applications, the first and the second coupling sites are coated with a tissue-growth-inhibiting coating.
- For some applications, the first tissue anchor includes a helical tissue-anchoring element.
- The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
-
FIGS. 1A-C are schematic illustrations of a method of treating a heart of a patient, in accordance with an application of the present invention; and -
FIGS. 2A-C are schematic illustrations of a method of treating a heart of a patient, in accordance with an application of the present invention. -
FIGS. 1A-C and 2A-C are schematic illustrations of methods of treating aheart 10 of a patient, in accordance with respective applications of the present invention. For some applications, the methods are performed to treat atricuspid valve 20, such as by reducing tricuspid valve regurgitation. - As shown in
FIGS. 1A and 2A , during a first stage of an implantation procedure, afirst tissue anchor 30 is implanted in cardiac tissue of the patient, such as in the vicinity oftricuspid valve 20.First tissue anchor 30 is attached to one ormore tethers 32 that are fixed to acoupling element 34, such as a hook, as shown inFIG. 1A , or an opening, as shown inFIG. 1B . Optionally,coupling element 34 comprises a loop, which is shaped so as to define the opening (configuration not shown). Optionally, acoupling support structure 36 is provided, which comprisescoupling element 34 and attachescoupling element 34 to the one ormore tethers 32. Asecond tissue anchor 40 is implanted in the patient, either before or after implantingfirst tissue anchor 30, such as in a superior vena cava (SVC) 42, an inferior vena cava (IVC) 44 (as shown), and acoronary sinus 46. Typically, first and second tissue anchors 30 and 40 are implanted in a transcatheter procedure (typically endovascularly, such as percutaneously), via a catheter, such as described in the applications incorporated hereinbelow by reference. Optionally, the one ormore tethers 32 comprise twotethers 32 that are coupled together in situ during the first stage of the implantation procedure, such as using techniques described in one or more of the applications incorporated by reference hereinbelow. - Also as shown in
FIGS. 1A and 2A ,coupling element 34 is coupled to afirst coupling site 50 ofsecond tissue anchor 40, thereby couplingfirst tissue anchor 30 tosecond tissue anchor 40 via the one ormore tethers 32. Couplingelement 34 may be coupled tofirst coupling site 50 either after or before implanting first and second tissue anchors 30 and 40, or after implantingfirst tissue anchor 30 and before implantingsecond tissue anchor 40. For some applications, at this first stage of the implantation procedure, the one ormore tethers 32 are slack, i.e., do not apply tension between first and second tissue anchors 30 and 40. - As shown in
FIGS. 1B-C and 2B-C, thereafter, during a second stage of the implantation procedure, typically after allowing at least 24 hours (e.g., at least one week, such as at least one month) for tissue growth (e.g., fibrous and/or endothelial tissue growth) onfirst tissue anchor 30 to strengthen anchoring offirst tissue anchor 30 in the cardiac tissue, tension is increased between first and second tissue anchors 30 and 40 bydecoupling coupling element 34 fromfirst coupling site 50 andcoupling coupling element 34 to asecond coupling site 52 of second tissue anchor 40 (different from first coupling site 50). For some applications, the tension is increased within two months after implantingfirst tissue anchor 30. Typically,second coupling site 52 is farther fromfirst tissue anchor 30 thanfirst coupling site 50 is fromfirst tissue anchor 30. Typically, application of the tension remodelstricuspid valve 20, by drawing two or three of the leaflets together to enhance coaptation. The procedure may optionally include subsequent stages (e.g., a third stage) after the second stage (e.g., at least 24 hours after the second stage), in which tension is further increased by decoupling coupling element from its current coupling site (e.g., coupling site 50) andcoupling coupling element 34 to yet another coupling site (e.g., a third coupling site). - Typically, in order to decouple
coupling element 34 fromfirst coupling site 50, during the second stage of the implantation procedure atool 54 is introduced through the vasculature via acatheter 56, and used to recapturecoupling element 34. For example,tool 54 may comprise alasso 58, which is used to engage ahook 60 ofcoupling element 34. The hook may extend radially inward into a lumen ofsecond tissue anchor 40 in order to facilitate engagement by tool 54 (e.g., lasso 58) whentool 54 has been introduced into the lumen ofsecond tissue anchor 40. - For some applications, as shown in the figures,
second tissue anchor 40 comprises astent 70 that comprises a plurality ofstruts 72, which define first andsecond coupling sites FIGS. 1A-C and 2A-C, first andsecond coupling sites coupling element 34 to first andsecond coupling sites stent 70. For some of these applications, such as shown inFIGS. 1A-C , one or more ofstruts 72 extend radially inward at first andsecond couplings sites coupling element 34 to first andsecond coupling sites stent 70. For others of these applications, such as shown inFIGS. 2A-C ,second tissue anchor 40 comprises hooks (which are optionally shaped as tabs, as shown inFIGS. 2A-C ) at first andsecond coupling sites second coupling sites strut 74, described immediately below) also extend radially inward). - For some applications, at least one 74 of
struts 72 is oriented axially along the stent, and axially-orientedstrut 74 defines first andsecond coupling sites strut 74 is wider than others ofstruts 72 so as to serve as a backbone for the stent. (Although not illustrated, this backbone may also be provided for the configuration shown inFIGS. 1A-C .) - For some applications,
first tissue anchor 30 comprises a helical tissue-anchoring element. For some applications, fibrous glue is applied to the tissue-coupling element to help secure the anchor in place and minimize detachment. Optionally, tissue-growth-enhancing coating is also applied to the tissue-coupling element. - For some applications,
coupling element 34 is afirst coupling element 34, and the one ormore tethers 32 are additionally fixed to asecond coupling element 78, such as a hook, as shown inFIGS. 1A-C , or an opening, as shown inFIGS. 2A-C (or to more than two coupling elements, such as shown inFIGS. 2A-C ); for example,coupling support structure 36, if provided, may comprisesecond coupling element 78 in addition tofirst coupling element 34. For these applications,coupling coupling element 34 tofirst coupling site 50 comprises coupling one or more of first andsecond coupling elements first coupling sites 50. Providing a plurality of coupling elements provides redundancy; in case one of the coupling elements does not catch onsecond tissue anchor 40, another of the coupling elements may catch (or both may catch, as shown in the figures). - For some applications, first and
second coupling elements coupling support structure 36, optionally at a distance apart that is the same as a distance between first andsecond coupling sites first coupling element 34 is repositioned fromfirst coupling site 50 to second coupling site, as described hereinabove with reference toFIGS. 1B-C and 2B-C,second coupling element 78 is repositioned from athird coupling site 80 tofirst coupling site 50, i.e., takes the coupling site vacated byfirst coupling element 34. - For some applications,
coupling element 34,first coupling site 50, and/orsecond coupling site 52 are coated with a tissue-growth-inhibiting coating (e.g., silicone). Such coating may facilitate the decoupling ofcoupling element 34 fromfirst coupling site 50 and/or the coupling ofcoupling element 34 tosecond coupling site 52, as described hereinabove with reference toFIGS. 1B-C and 2B-C. - The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:
-
- U.S. Pat. No. 8,475,525 to Maisano et al.;
- U.S. Pat. No. 8,961,596 to Maisano et al.;
- U.S. Pat. No. 8,961,594 to Maisano et al.;
- PCT Publication WO 2011/089601;
- U.S. Pat. No. 9,241,702 to Maisano et al.;
- PCT Publication WO 2013/011502;
- U.S. Provisional Application 61/750,427, filed Jan. 9, 2013;
- U.S. Provisional Application 61/783,224, filed Mar. 14, 2013;
- PCT Publication WO 2013/179295;
- U.S. Provisional Application 61/897,491, filed Oct. 30, 2013;
- U.S. Provisional Application 61/897,509, filed Oct. 30, 2013;
- U.S. Pat. No. 9,307,980 to Gilmore et al.;
- PCT Publication WO 2014/108903;
- PCT Publication WO 2014/141239;
- U.S. Provisional Application 62/014,397, filed Jun. 19, 2014;
- PCT Publication WO 2015/063580;
- US Patent Application Publication 2015/0119936;
- U.S. Provisional Application 62/086,269, filed Dec. 2, 2014;
- U.S. Provisional Application 62/131,636, filed Mar. 11, 2015;
- U.S. Provisional Application 62/167,660, filed May 28, 2015;
- PCT Publication WO 2015/193728;
- PCT Publication WO 2016/087934;
- US Patent Application Publication 2016/0242762;
- PCT Publication WO 2016/189391;
- US Patent Application Publication 2016/0262741; and
- U.S. Provisional Application 62/376,685, filed Aug. 18, 2016.
- It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims (22)
1. A method of treating a heart of a patient, comprising:
implanting a first tissue anchor in cardiac tissue of the patient, the first tissue anchor attached to one or more tethers that are fixed to a coupling element;
implanting a second tissue anchor in the patient;
coupling the coupling element to a first coupling site of the second tissue anchor, thereby coupling the first tissue anchor to the second tissue anchor via the one or more tethers; and
thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, increasing tension between the first and the second tissue anchors by decoupling the coupling element from the first coupling site and coupling the coupling element to a second coupling site of the second tissue anchor.
2. The method according to claim 1 , wherein the one or more tethers are slack before increasing the tension.
3. The method according to claim 1 , wherein the coupling element comprises a hook.
4. The method according to claim 1 , wherein the coupling element is shaped so as to define an opening, and wherein coupling the coupling element to the first coupling site comprises coupling the opening to the first coupling site.
5. The method according to claim 4 , wherein the coupling element comprises a loop, which is shaped to define the opening.
6. The method according to claim 1 , wherein the second tissue anchor comprises a stent that comprises a plurality of struts, which define the first and the second coupling sites.
7. The method according to claim 6 , wherein the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
8. The method according to claim 7 , wherein one or more of the struts extend radially inward at the first and the second couplings sites to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
9. The method according to claim 7 , wherein the second tissue anchor comprises hooks at the first and the second coupling sites, respectively.
10. The method according to claim 6 , wherein at least one of the struts is oriented axially along the stent, and the axially-oriented strut defines the first and the second coupling sites.
11. The method according to claim 10 , wherein the first and the second coupling sites extend radially inward to facilitate the coupling of the coupling element to the first and the second coupling sites from within the stent.
12. (canceled)
13. The method according to claim 1 , wherein increasing the tension comprises increasing the tension after allowing at least one week for tissue growth on the first tissue anchor.
14. The method according to claim 1 , wherein increasing the tension comprises increasing the tension within two months after implanting the first tissue anchor.
15. The method according to claim 1 , wherein the coupling element is a first coupling element, and the one or more tethers are additionally fixed to a second coupling element, and wherein coupling the coupling element to the first coupling site comprises coupling one or more of the first and the second coupling elements to a plurality of first coupling sites.
16. The method according to claim 1 , wherein coupling the coupling element to the first coupling site comprises coupling the coupling element to the first coupling site after implanting the first and the second tissue anchors.
17. The method according to claim 1 , wherein coupling the coupling element to the first coupling site comprises coupling the coupling element to the first coupling site before implanting the first and the second tissue anchors.
18. The method according to claim 1 , wherein coupling the coupling element to the first coupling site comprises coupling the coupling element to the first coupling site after implanting the first tissue anchor and before implanting the second tissue anchor.
19-20. (canceled)
21. The method according to claim 1 , wherein the first tissue anchor comprises a helical tissue-anchoring element.
22. The method according to claim 1 , wherein implanting the first tissue anchor comprises implanting the first tissue anchor in the vicinity of the tricuspid valve of the patient.
23. The method according to claim 1 , wherein implanting the second tissue anchor comprises implanting the second tissue anchor in a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/564,809 US20200022696A1 (en) | 2017-03-01 | 2019-09-09 | Post-Implantation Tension Adjustment in Cardiac Implants |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465400P | 2017-03-01 | 2017-03-01 | |
US15/903,619 US10441266B2 (en) | 2017-03-01 | 2018-02-23 | Post-implantation tension adjustment in cardiac implants |
US16/564,809 US20200022696A1 (en) | 2017-03-01 | 2019-09-09 | Post-Implantation Tension Adjustment in Cardiac Implants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/903,619 Continuation US10441266B2 (en) | 2017-03-01 | 2018-02-23 | Post-implantation tension adjustment in cardiac implants |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200022696A1 true US20200022696A1 (en) | 2020-01-23 |
Family
ID=61599638
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/903,619 Expired - Fee Related US10441266B2 (en) | 2017-03-01 | 2018-02-23 | Post-implantation tension adjustment in cardiac implants |
US16/564,809 Abandoned US20200022696A1 (en) | 2017-03-01 | 2019-09-09 | Post-Implantation Tension Adjustment in Cardiac Implants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/903,619 Expired - Fee Related US10441266B2 (en) | 2017-03-01 | 2018-02-23 | Post-implantation tension adjustment in cardiac implants |
Country Status (2)
Country | Link |
---|---|
US (2) | US10441266B2 (en) |
WO (1) | WO2018160456A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014141239A1 (en) * | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
US11696828B2 (en) | 2016-12-30 | 2023-07-11 | Pipeline Medical Technologies, Inc. | Method and apparatus for mitral valve chord repair |
US11083580B2 (en) | 2016-12-30 | 2021-08-10 | Pipeline Medical Technologies, Inc. | Method of securing a leaflet anchor to a mitral valve leaflet |
US9877833B1 (en) | 2016-12-30 | 2018-01-30 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US10925731B2 (en) | 2016-12-30 | 2021-02-23 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
WO2020139776A1 (en) | 2018-12-24 | 2020-07-02 | 4Tech Inc. | Self-locking tissue anchors |
IT202000012562A1 (en) | 2020-05-27 | 2021-11-27 | Milano Politecnico | DEVICE AND ASSEMBLY FOR REPAIRING A HEART VALVE |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3230858C2 (en) | 1982-08-19 | 1985-01-24 | Ahmadi, Ali, Dr. med., 7809 Denzlingen | Ring prosthesis |
ES2049653B1 (en) | 1992-10-05 | 1994-12-16 | Velazquez Francisco Farrer | CORRECTIVE DEVICE FOR FEMALE URINARY INCONTINENCE. |
AU9225598A (en) | 1997-09-04 | 1999-03-22 | Endocore, Inc. | Artificial chordae replacement |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
ATE492219T1 (en) | 1999-04-09 | 2011-01-15 | Evalve Inc | DEVICE FOR HEART VALVE OPERATION |
US6997951B2 (en) * | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6997944B2 (en) | 2001-08-13 | 2006-02-14 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for decreasing stent gap size |
WO2003016863A2 (en) * | 2001-08-17 | 2003-02-27 | United Chemical Technologies | Apparatus for simultaneous processing of multiple samples |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US8758372B2 (en) | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US7335213B1 (en) | 2002-11-15 | 2008-02-26 | Abbott Cardiovascular Systems Inc. | Apparatus and methods for heart valve repair |
US20040186566A1 (en) | 2003-03-18 | 2004-09-23 | Hindrichs Paul J. | Body tissue remodeling methods and apparatus |
US20060282161A1 (en) | 2003-06-20 | 2006-12-14 | Medtronic Vascular, Inc. | Valve annulus reduction system |
US7316706B2 (en) | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
EP2526898B1 (en) | 2003-12-23 | 2013-04-17 | Sadra Medical, Inc. | Repositionable heart valve |
US20050177224A1 (en) | 2004-02-11 | 2005-08-11 | Fogarty Thomas J. | Vascular fixation device and method |
US7520720B2 (en) * | 2004-07-28 | 2009-04-21 | Sta-Rite Industries, Llc | Pump |
US7455681B2 (en) | 2004-09-13 | 2008-11-25 | Wound Care Technologies, Llc | Wound closure product |
US8608797B2 (en) | 2005-03-17 | 2013-12-17 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
SE531468C2 (en) | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US7500989B2 (en) * | 2005-06-03 | 2009-03-10 | Edwards Lifesciences Corp. | Devices and methods for percutaneous repair of the mitral valve via the coronary sinus |
US9492277B2 (en) | 2005-08-30 | 2016-11-15 | Mayo Foundation For Medical Education And Research | Soft body tissue remodeling methods and apparatus |
US20070118151A1 (en) | 2005-11-21 | 2007-05-24 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
WO2007100408A2 (en) | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems & methods |
US8932348B2 (en) * | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US20070282429A1 (en) | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
US9131928B2 (en) | 2007-12-20 | 2015-09-15 | Mor Research Applications Ltd. | Elongated body for deployment in a heart |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US20090276040A1 (en) * | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US8808368B2 (en) | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
US20110011917A1 (en) | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
US20100217382A1 (en) | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US9241702B2 (en) * | 2010-01-22 | 2016-01-26 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US9307980B2 (en) * | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US8961596B2 (en) | 2010-01-22 | 2015-02-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
WO2013021374A2 (en) * | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8900295B2 (en) * | 2011-09-26 | 2014-12-02 | Edwards Lifesciences Corporation | Prosthetic valve with ventricular tethers |
US8961594B2 (en) | 2012-05-31 | 2015-02-24 | 4Tech Inc. | Heart valve repair system |
EP2943132B1 (en) | 2013-01-09 | 2018-03-28 | 4Tech Inc. | Soft tissue anchors |
WO2014141239A1 (en) | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
CA2917573A1 (en) | 2013-07-11 | 2015-01-15 | Shifamed Holdings, Llc | Devices and methods for lung volume reduction |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
US9801720B2 (en) | 2014-06-19 | 2017-10-31 | 4Tech Inc. | Cardiac tissue cinching |
WO2016087934A1 (en) | 2014-12-02 | 2016-06-09 | 4Tech Inc. | Off-center tissue anchors |
US10765539B2 (en) * | 2015-05-27 | 2020-09-08 | W. L. Gore & Associates, Inc. | Stent graft device with anchoring members having adjustable geometries |
WO2016189391A2 (en) | 2015-05-28 | 2016-12-01 | 4Tech Inc. | Off-center tissue anchors with tension members |
US9592121B1 (en) * | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
JP6718189B2 (en) | 2017-02-08 | 2020-07-08 | 4テック インコーポレイテッド | Tensioning after implantation in heart implantation |
CN111493925A (en) | 2017-02-08 | 2020-08-07 | 4科技有限公司 | Implanted dynamometer |
-
2018
- 2018-02-23 WO PCT/US2018/019420 patent/WO2018160456A1/en active Application Filing
- 2018-02-23 US US15/903,619 patent/US10441266B2/en not_active Expired - Fee Related
-
2019
- 2019-09-09 US US16/564,809 patent/US20200022696A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US10441266B2 (en) | 2019-10-15 |
US20180249993A1 (en) | 2018-09-06 |
WO2018160456A1 (en) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10441266B2 (en) | Post-implantation tension adjustment in cardiac implants | |
US10682229B2 (en) | Post-implantation tensioning in cardiac implants | |
US20220313424A1 (en) | Platforms For Mitral Valve Replacement | |
US20210145580A1 (en) | Post-implantation tensioning in cardiac implants | |
US20210000595A1 (en) | Transcatheter valve devices and systems | |
US20180185179A1 (en) | Stent with Tether Interfaces | |
US8357195B2 (en) | Catheter based annuloplasty system and method | |
US20140074223A1 (en) | Multiple Orifice Implantable Heart Valve and Methods of Implantation | |
US20070061010A1 (en) | Device and method for reshaping mitral valve annulus | |
US20220192826A1 (en) | Low profile prosthetic mitral valve | |
US20240016609A1 (en) | Mitral valve implants | |
US20140155993A1 (en) | Device for mitigating or preventing paravalvular leaks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: 4TECH INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DENTI, PAOLO;GUIDOTTI, ANDREA;LYNN, KEVIN;AND OTHERS;SIGNING DATES FROM 20170227 TO 20170425;REEL/FRAME:050330/0810 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |